Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.
Oxelmark
Lena
L
Department of Medicine, Karolinska University Hospital, Solna, Sweden. lena.oxelmark@ki.se
Hillerås
Pernilla
P
Dignass
Axel
A
Mössner
Joachim
J
Schreiber
Stefan
S
Kruis
Wolfgang
W
Löfberg
Robert
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006304:Health Status; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007937:Leukapheresis; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D007155:Immunologic Factors; D019804:Mesalamine